
|Articles|December 13, 2004
Technology Update: FDA and drugmakers tout tags to foil counterfeits
The FDA has published a compliance policy guide for implementing feasibility studies and pilot programs for radio frequency identification (RFID) technology to deter counterfeiting and diversion. The agency has also created an internal RFID Workgroup to monitor the adoption of RFID technology in the prescription drug supply chain. (For more on RFID )
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Merck Shares Access Strategy for Investigational Monthly PrEP Alimatravir
2
Post-Pandemic Vaccine Gaps Mirror Socioeconomic Disparities
3
FDA Approves First-in-Class Centanafadine for Treatment of ADHD
4
The 3 Perspectives of 340B: Legal, Safety-Net, and Purchaser
5























